X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (9160) 9160
life sciences & biomedicine (8485) 8485
animals (8070) 8070
interleukin-1beta - metabolism (5300) 5300
humans (5289) 5289
male (4629) 4629
mice (4040) 4040
inflammation (3005) 3005
rats (2806) 2806
cells, cultured (2775) 2775
tumor necrosis factor-alpha - metabolism (2617) 2617
interleukin-1beta - pharmacology (2599) 2599
female (2330) 2330
immunology (2170) 2170
cytokines (2032) 2032
pharmacology & pharmacy (1986) 1986
interleukin-1beta - genetics (1983) 1983
cell biology (1661) 1661
nf-kappa b - metabolism (1650) 1650
disease models, animal (1529) 1529
cell line (1486) 1486
mice, inbred c57bl (1413) 1413
interleukin-6 - metabolism (1384) 1384
rats, sprague-dawley (1362) 1362
biochemistry & molecular biology (1309) 1309
lipopolysaccharides - pharmacology (1305) 1305
signal transduction - drug effects (1266) 1266
il-1β (1254) 1254
anti-inflammatory agents - pharmacology (1213) 1213
rna, messenger - metabolism (1121) 1121
gene expression (1115) 1115
signal transduction (999) 999
interleukin-1beta - immunology (982) 982
tumor necrosis factor-alpha - genetics (972) 972
rats, wistar (971) 971
neurosciences (938) 938
neurosciences & neurology (935) 935
research article (917) 917
analysis (915) 915
macrophages - drug effects (911) 911
enzyme-linked immunosorbent assay (903) 903
dose-response relationship, drug (890) 890
rodents (877) 877
interleukin-1beta - blood (874) 874
interleukin-1beta - biosynthesis (857) 857
inflammation - metabolism (830) 830
macrophages - metabolism (826) 826
gene expression regulation - drug effects (811) 811
proteins (805) 805
apoptosis (790) 790
middle aged (777) 777
tumor necrosis factor-alpha - pharmacology (771) 771
medicine, research & experimental (761) 761
research & experimental medicine (761) 761
adult (756) 756
research (734) 734
macrophages (729) 729
rna, messenger - genetics (722) 722
cytokines - metabolism (716) 716
reverse transcriptase polymerase chain reaction (704) 704
interleukins (701) 701
apoptosis - drug effects (691) 691
lipopolysaccharides (691) 691
blotting, western (683) 683
cyclooxygenase 2 - metabolism (679) 679
time factors (667) 667
mice, knockout (658) 658
medicine (649) 649
cell survival - drug effects (644) 644
nitric oxide synthase type ii - metabolism (639) 639
science & technology - other topics (631) 631
nitric oxide - metabolism (617) 617
inflammation - drug therapy (615) 615
interleukin-6 - genetics (604) 604
multidisciplinary sciences (600) 600
abridged index medicus (597) 597
cell line, tumor (594) 594
rheumatology (594) 594
mice, inbred balb c (585) 585
inflammation mediators - metabolism (570) 570
health aspects (561) 561
phosphorylation (559) 559
nitric oxide (556) 556
interleukin-1beta - antagonists & inhibitors (555) 555
reactive oxygen species - metabolism (546) 546
tumor necrosis factor-alpha - blood (542) 542
interleukin-1β (534) 534
physiology (525) 525
pathology (517) 517
chondrocytes - drug effects (510) 510
physiological aspects (509) 509
oxidative stress (497) 497
aged (495) 495
plant extracts - pharmacology (492) 492
tumor necrosis factor-α (492) 492
kinases (490) 490
inflammasomes - metabolism (485) 485
science (484) 484
caspase 1 - metabolism (476) 476
interleukin (473) 473
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11307) 11307
Chinese (324) 324
Japanese (109) 109
Russian (22) 22
Portuguese (18) 18
Norwegian (5) 5
French (3) 3
German (3) 3
Ukrainian (3) 3
Italian (2) 2
Korean (2) 2
Spanish (2) 2
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of neurochemistry, ISSN 0022-3042, 09/2011, Volume 118, Issue 5, pp. 826 - 840
J. Neurochem. (2011) 118, 826–840. Inflammation contributes to neurodegeneration in post‐ischemic brain, diabetes, and Alzheimer’s disease. Participants in... 
gap junctions | Alzheimer’s disease | amyloid β‐peptide | cytokines | diabetes mellitus | pannexin | stroke | connexin | amyloid β-peptide | Alzheimer's disease | Biochemistry & Molecular Biology | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Tumor Necrosis Factor-alpha - metabolism | Oxygen - pharmacology | Cell Hypoxia - physiology | Amyloid beta-Peptides - pharmacology | Microtubule-Associated Proteins - pharmacology | Culture Media, Conditioned - pharmacology | Lanthanum - pharmacology | Peptide Fragments - pharmacology | Cerebral Cortex - cytology | Adenosine Triphosphate - pharmacology | Time Factors | Interleukin-1beta - metabolism | Adenosine Triphosphate - metabolism | Neuropeptides - pharmacology | Nerve Tissue Proteins - pharmacology | Neurons - physiology | Astrocytes - chemistry | Female | Cell Death - drug effects | Connexins - pharmacology | Neurons - drug effects | Animals, Newborn | Astrocytes - drug effects | Cell Hypoxia - drug effects | Connexin 43 - metabolism | Glutamic Acid - pharmacology | Cells, Cultured | Fluoresceins | Coculture Techniques - methods | Connexin 43 - deficiency | Connexins - metabolism | Mice, Knockout | Nerve Tissue Proteins - metabolism | Animals | Biotinylation - methods | Glutamic Acid - metabolism | Mice | Astrocytes - metabolism | Methyl aspartate | Peptides | Neurons | Diabetes | Glucose | Glutamate | Dextrose | Index Medicus
Journal Article
Journal Article
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 07/2013, Volume 98, Issue 7, pp. E1163 - E1172
Context: Inhibition of dipeptidyl peptidase-4 (DPP-4) is a potent strategy to increase glucose-dependent insulinotropic polypeptide and glucagon like peptide 1... 
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Palmitic Acid - metabolism | Dipeptidyl Peptidase 4 - metabolism | Antioxidants - chemistry | Dipeptidyl Peptidase 4 - chemistry | Humans | Interleukin 1 Receptor Antagonist Protein - genetics | Peptide Fragments - pharmacology | Interleukin-1beta - genetics | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Insulin-Secreting Cells - metabolism | Anti-Inflammatory Agents, Non-Steroidal - antagonists & inhibitors | Glucagon-Like Peptide 1 - agonists | Interleukin-1beta - metabolism | Interleukin 1 Receptor Antagonist Protein - metabolism | Purines - antagonists & inhibitors | Linagliptin | Interleukin 1 Receptor Antagonist Protein - pharmacology | Sitagliptin Phosphate | Insulin Secretion | Interleukin-1beta - antagonists & inhibitors | Recombinant Proteins - metabolism | Cell Survival - drug effects | Recombinant Proteins - antagonists & inhibitors | Cytokines - metabolism | Glucagon-Like Peptide 1 - metabolism | Purines - pharmacology | Tissue Culture Techniques | Dipeptidyl-Peptidase IV Inhibitors - chemistry | Glucagon-Like Peptide 1 - chemistry | Antioxidants - pharmacology | Recombinant Proteins - pharmacology | Insulin-Secreting Cells - immunology | Triazoles - pharmacology | Insulin - metabolism | Insulin-Secreting Cells - drug effects | Drug Inverse Agonism | Protein Stability - drug effects | Pyrazines - pharmacology | Quinazolines - pharmacology | Quinazolines - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 2012, Volume 254, Issue 1, pp. 10 - 18
Journal Article
Neuroscience, ISSN 0306-4522, 05/2014, Volume 268, pp. 236 - 246
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 10/2013, Volume 110, Issue 43, pp. 17558 - 17563
Proinflammatory macrophages are key mediators in several pathologies; thus, controlling their activation is necessary. The endocannabinoid system is implicated... 
Enzymes | Receptors | Antiinflammatories | Messenger RNA | Cell lines | Macrophage activation | Inflammation | Macrophages | Endocannabinoids | Cannabinoid receptors | FAAH | Glyceryl prostaglandin | COX-2 | Anandamide | Prostaglandin synthase | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Endocannabinoids - metabolism | Inflammation - chemically induced | Endocannabinoids - pharmacology | Gene Expression - drug effects | Monoacylglycerol Lipases - antagonists & inhibitors | Male | Interleukin-1beta - genetics | Monoacylglycerol Lipases - genetics | Monoacylglycerol Lipases - metabolism | Arachidonic Acids - metabolism | Inflammation - metabolism | Biphenyl Compounds - pharmacology | Cyclooxygenase 2 - genetics | Esters - chemistry | Interleukin-1beta - metabolism | Lipocalins - genetics | Prostaglandin D2 - metabolism | Female | Glycerol - chemistry | Intramolecular Oxidoreductases - metabolism | Carbamates - pharmacology | Lipocalins - metabolism | Cell Line | Lipopolysaccharides - toxicity | Enzyme-Linked Immunosorbent Assay | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Cells, Cultured | Enzyme Inhibitors - pharmacology | Glycerides - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Arachidonic Acids - pharmacology | Prostaglandin D2 - chemistry | Glycerides - pharmacology | Macrophages - metabolism | Animals | Anti-Inflammatory Agents - chemistry | Intramolecular Oxidoreductases - genetics | Cyclooxygenase 2 - metabolism | Macrophages - drug effects | Inflammation - prevention & control | Mice | Prostaglandin D2 - pharmacology | Macrophage Activation - drug effects | Prostaglandins | Physiological aspects | Lipid metabolism | Research | Health aspects | Index Medicus | prostaglandin synthase | Biological Sciences | glyceryl prostaglandin | anandamide
Journal Article
British journal of nutrition, ISSN 0007-1145, 01/2009, Volume 102, Issue 2, pp. 201 - 206
Journal Article